![Johnson & Johnson medicine production](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/shutterstock_2475737579-375x211.jpg)
Johnson & Johnson Innovative Medicine is planning to invest a total of €580 million in
For example, the plant produces over four billion tablets every year, spanning approximately 30 different products, J&J confirmed.
Increasing production capacity with advanced technology
"The
Lopez told EPR that J&J "are building capabilities for the future by investing in technology and in our workforce to ensure we remain resilient to reliably and efficiently supply our innovative medicines".
Production capacity is expected to increase over 25 per cent because of the financing, J&J reported.
"These new technologies will enable us to be more agile and efficient at the site… by performing certain processes simultaneously rather than in sequence”
"These new technologies will enable us to be more agile and efficient at the site by improving how we manage the packaging of small production batches and reducing end-to-end manufacturing time by performing certain processes simultaneously rather than in sequence," Lopez continued.
He highlighted that a key challenge J&J faced when incorporating the planned new production technologies was to upskill its employees "to ensure we had the capabilities to not only identify opportunities for innovation but also implement solutions".
Driving innovation
This is because "we are driving innovation directly rather than buying an off the shelf product," he explained. For example, Lopez added that this is being done by developing new automated and data-driven processes to enhance efficiency and speed.
"We trust that innovation will continue to be welcomed and properly recognised, that the clinical trials ecosystem will improve and get faster and that constructive dialogue between institutions and the industry - already opened by the Government - continues and remains open," commented Mario Sturion, Managing Director of Johnson & Johnson Innovative Medicine Italy.
“Growth [of investments in
Advancing targeted treatments for multiple myeloma
The post J&J commits five-year investment in Italian medicine manufacturing appeared first on European Pharmaceutical Review.
© Russell Publishing Limited, 2024. All Rights Reserved., source